Varma Sandeep R, Sharath Kumar L M, Vidyashankar Satyakumar, Patki Pralhad Sadashiv
Department of Cell Biology, Research and Development, The Himalaya Drug Company, Bangalore-562 162, India.
Department of Phytochemistry, Research and Development, The Himalaya Drug Company, Bangalore-562 162, India.
Sci Pharm. 2014 Feb 8;82(2):375-91. doi: 10.3797/scipharm.1310-25. Print 2014 Apr-Jun.
Osteocare, a herbal formulation, has been found to be very effective in bone mineralization and support of the microstructure of bone tissue. The water-soluble components of Osteocare (WSCO) induced osteogenic activity in human osteoblast-like SaOS-2 cells. The addition of WSCO (100 μg/ml) to SaOS-2 cells was effective in increasing the cell proliferation by 41.49% and DNA content by 1.9-fold. WSCO increased matrix mineralization in SaOS-2 cells by increased alkaline phosphatase levels and calcium-rich deposits as observed by Alizarin red staining. WSCO markedly increased mRNA expression for osteopontin (OPN), osteocalcin (OCN), type I collagen (Col I) in SaOS-2 cells, and it down-regulated IL-6 mRNA levels in SaOS-2 cells. The present study showed that WSCO plays an important role in osteoblastic bone formation through enhanced activities of ALP, Col I, bone matrix proteins such as OPN and OCN, down-regulation of cytokines like IL-6, as well as promoting mineralization in SaOS-2 cells.
奥斯特卡尔(Osteocare)是一种草药配方制剂,已被发现对骨矿化和骨组织结构的维持非常有效。奥斯特卡尔的水溶性成分(WSCO)在人成骨样SaOS-2细胞中诱导了成骨活性。向SaOS-2细胞中添加WSCO(100μg/ml)可有效使细胞增殖增加41.49%,DNA含量增加1.9倍。如茜素红染色所示,WSCO通过提高碱性磷酸酶水平和富含钙的沉积物增加了SaOS-2细胞中的基质矿化。WSCO显著增加了SaOS-2细胞中骨桥蛋白(OPN)、骨钙素(OCN)、I型胶原蛋白(Col I)的mRNA表达,并下调了SaOS-2细胞中IL-6的mRNA水平。本研究表明,WSCO通过增强碱性磷酸酶、I型胶原蛋白、骨基质蛋白如OPN和OCN的活性,下调细胞因子如IL-6,以及促进SaOS-2细胞矿化,在成骨细胞骨形成中发挥重要作用。